13,510
Total Claims
$2.1M
Drug Cost
1,521
Beneficiaries
$1,370
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-10%
Cost per patient vs peers
$1,370 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 11,534 claims · $278K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 753 | $797K |
| Rivaroxaban | 267 | $310K |
| Sacubitril/Valsartan | 214 | $270K |
| Evolocumab | 95 | $98K |
| Dronedarone Hcl | 48 | $61K |
| Ticagrelor | 42 | $38K |
| Azilsartan Med/Chlorthalidone | 90 | $31K |
| Dapagliflozin Propanediol | 24 | $24K |
| Nebivolol Hcl | 241 | $23K |
| Empagliflozin | 21 | $21K |
| Clopidogrel Bisulfate | 1,064 | $21K |
| Alirocumab | 24 | $19K |
| Atorvastatin Calcium | 1,279 | $19K |
| Ranolazine | 97 | $19K |
| Evolocumab | 28 | $18K |
Prescribing Profile
85
Unique Drugs
$1.4M
Patient Profile
74
Avg Age
51%
Female
1.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data